| For: | Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer. World J Gastroenterol 2023; 29(10): 1569-1588 [PMID: 36970592 DOI: 10.3748/wjg.v29.i10.1569] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i10/1569.htm |
| Number | Citing Articles |
| 1 |
Yilin Yu, Haixia Wu, Liang Hong, Jianjian Qiu, Shiji Wu, Lingdong Shao, Cheng Lin, Zhiping Wang, Junxin Wu. A large population-based and validated study on the follow-up management and supportive strategy of locally advanced rectal cancer patients. Supportive Care in Cancer 2024; 32(10) doi: 10.1007/s00520-024-08860-1
|
| 2 |
Jun-ping Lei, Lin Wang, Tian-yang Wang, Bing-hu Lin, Yan Xu, Song Shang, Tian Xia, Min-ming Gong, Yu Guo, Jia Fu, Yuan-lin Li. LINC02878/ZNF282/PYCR2 axis promotes proline synthesis and tumor progression in colorectal cancer. Cellular and Molecular Life Sciences 2025; 83(1) doi: 10.1007/s00018-025-05968-3
|
| 3 |
Marwa Abdel Hamid, Lorenz M. Pammer, Theresa K. Lentner, Bernhard Doleschal, Rebecca Gruber, Florian Kocher, Elisabeth Gasser, Anna Jöbstl, Andreas Seeber, Arno Amann. Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?. Current Oncology Reports 2024; 26(10) doi: 10.1007/s11912-024-01583-w
|
| 4 |
Lunxi Liang, Xueer Yang, Shuoyi Yao, Xinmeng Li, Fen Wang. Identification of lactylation-associated fibroblast subclusters predicting prognosis and cancer immunotherapy response in colon cancer. Gene 2025; 940 doi: 10.1016/j.gene.2025.149220
|
| 5 |
Jia Xuan Kee, Jia Ning Nicolette Yau, Ram Pravin Kumar Muthuramalingam, Xinyi Wang, Wei Heng Chng, Alvaro Lopez-Sanchez, Kevin Kuang Wei Tay, Lih-Wen Deng, Dan Gibson, Helene C. Bertrand, Giulia Adriani, Wee Han Ang, Giorgia Pastorin. Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs. Chemical Reviews 2025; 125(21) doi: 10.1021/acs.chemrev.5c00041
|
| 6 |
Junjiang Wang, Chunsheng Liu, Ping Wang, Zhiyuan Liu, Weixian Hu, Zejian Lv, Chengzhi Huang, Xueqing Yao. Bioengineered Tumor‐Derived Extracellular Vehicles Suppressed Colorectal Cancer Liver Metastasis and Bevacizumab Resistance. Advanced Science 2025; 12(23) doi: 10.1002/advs.202417714
|
| 7 |
Xiaoyuan Qiu, Ruiqiang Li, Jiaolin Zhou, Peng Li, Gengchen Xie, Shenyi Yin, Leilei Yang, Guole Lin. Personalizing colorectal Cancer treatment: Chemotherapy drug testing with patient-derived tumor cell clusters. Translational Oncology 2025; 61 doi: 10.1016/j.tranon.2025.102518
|
| 8 |
Meng-Che Hsieh, Kun-Ming Rau, Kuang-Wen Liu, Chong-Chi Chiu, Chih-I Chen, Ling-Chiao Song, Hsin-Pao Chen. Association of RAS mutational status with clinical outcomes in metastatic colorectal cancer treated with trifluridine/tipiracil or regorafenib. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-36509-y
|
| 9 |
He Duan, XueChun Zhang, GongPing Sun. Methyltransferase-like 3 Inhibits Ferroptosis and Mitochondrial Dysfunction in Colorectal Cancer Cells and Promotes Their Lung Metastasis by Downregulating Protein Kinase AMP-activated Catalytic Subunit alpha 2 through m6A Modification. Journal of Evolutionary Biochemistry and Physiology 2026; 62(2) doi: 10.1134/S0022093025600666
|
| 10 |
Wenqing Chen, Xiangrui Li, Jiayue Xia, Da Pan, Xiaotian Chen, Guiju Sun. Research Progress on the Prognostic Significance of Systemic Immune Inflammation Index in Patients With Resected Colorectal Cancer: A Meta‐Analysis. Geriatrics & Gerontology International 2025; 25(11) doi: 10.1111/ggi.70197
|
| 11 |
Vaagdevi Mukkavilli, Gnanasekaran Ramakrishnan, Koteswara Reddy Gujjula, Balachandran S, Sahiti Chamarthy, Janaki Ramaiah Mekala. Molecular Understanding and Pharmacological Potency of Plant-Derived Compounds in Colorectal Cancer (CRC): A Critical Analysis and Future Perspectives. Cell Biochemistry and Biophysics 2024; 82(3) doi: 10.1007/s12013-024-01370-1
|
| 12 |
Yu Zhang, Jianguo Sun, Zexu Chen. Crotonoside exerts anti-colorectal cancer effects by suppressing KIF20A to regulate the cell cycle. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-24969-7
|
| 13 |
Jian Feng Bin, Long Fei Chen, Yan Wang, Hua Ge, Wei Chen. Bibliometric and visual analysis of global crc circular RNA research 2015-2023. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1580405
|
| 14 |
Francisco Cezar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Jonathan N. Priantti, Jhonny Limachi-Choque, Rommel Mario Rodríguez Burbano. Efficacy and Safety of Anti-EGFR Therapy Rechallenge in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-024-01128-1
|
| 15 |
Yanbin Chen, Xiaodong Xu, Xinye Hu. Design and fabrication of polymer-coated vincristine-loaded core − shell iron nanoparticle system with mitochondrial-targeted ultrasound improved colorectal cancer therapy. Journal of Biomaterials Science, Polymer Edition 2025; 36(15) doi: 10.1080/09205063.2025.2501095
|
| 16 |
Po-Jung Chen. Outcomes of upfront primary tumor resection in patients with synchronous RAS wild-type metastatic colorectal cancer. American Journal of Cancer Research 2024; 14(12) doi: 10.62347/DLWI1455
|
| 17 |
Pankaj Kumar Tripathi, Chakresh Kumar Jain. Unravelling colorectal cancer mechanisms: Insights from a regulatory network of ncRNAs, TFs, and mutated genes. Human Gene 2025; 45 doi: 10.1016/j.humgen.2025.201447
|
| 18 |
Wen-Yu Luan, Hao Lin, Yan-Dong Miao. Recommendations for articles and reviews in colorectal cancer-related research at the year-end of 2023. World Journal of Gastroenterology 2024; 30(30): 3548-3553 doi: 10.3748/wjg.v30.i30.3548
|
| 19 |
Yanrong Zhan, Xianwen Cheng, Pingping Mei, Shufa Tan, Wenzhe Feng, Hua Jiang. Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12662-3
|
| 20 |
Qingzhe Wang, Min Yu, Shuang Zhang. The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies. Frontiers in Immunology 2025; 15 doi: 10.3389/fimmu.2024.1440830
|
| 21 |
Xiaoxue Pan, Jichang Li, Jing Zhu, Xin Wang, Yucun Liu, Xiaodong Tian, Yinmo Yang, Pengyuan Wang, Shanwen Chen. SLC7A11-specific CAR-T cell therapy potently targets colorectal and pancreatic cancer. iScience 2025; 28(11) doi: 10.1016/j.isci.2025.113713
|
| 22 |
Fengxiang Huang, Haiyan Yang, Wenguang Bao, Yehong Bin, Shengsheng Zhou, Man Wang, Xiaoping Lv. Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis. Clinical and Translational Oncology 2023; 26(2) doi: 10.1007/s12094-023-03268-5
|
| 23 |
Wen-Tao Zhong, Yuan Lv, Qian-Yu Wang, Ran An, Gang Chen, Jun-Feng Du. Chemoradiotherapy plus tislelizumab for mismatch repair proficient rectal cancer with supraclavicular lymph node metastasis: A case report. World Journal of Gastrointestinal Oncology 2024; 16(5): 2219-2224 doi: 10.4251/wjgo.v16.i5.2219
|
| 24 |
Jichao Zhu, Jiliang Zhang, Chao Gu. Prognostic and clinicopathological value of soluble programmed cell death ligand-1 (sPD-L1) in patients with colorectal cancer: a meta-analysis. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03949-1
|
| 25 |
Hao Che, Zhen-Jun Li, Ling Xu, Yang-Bing Du, Song-Ou Zhang, Xiao-Jiang Ying. Advances in mitochondrial-targeted colorectal cancer therapy: Mechanistic insights and clinical translation. iScience 2026; 29(2) doi: 10.1016/j.isci.2025.114511
|
| 26 |
Mengying Kou, Ying Deng. Circulating tumor DNA as a predictive biomarker for treatment response and survival in metastatic colorectal cancer. International Journal of Colorectal Disease 2024; 39(1) doi: 10.1007/s00384-024-04785-7
|
| 27 |
Yinghao Cao, Jun Wang, Hanwenchen Wang, Xiang Sun, Fang Fang, Shiying Li, Jianping Liu, Changrong Shi, Pengyuan Qi, Jianhua Zou, Xiaoyuan Chen, Kailin Cai. Targeting Peptostreptococcus anaerobius with an Iron‐Based Nanozyme Reverses Ferroptosis Resistance and Enhances Antitumor Immunity in Colorectal Cancer. Advanced Science 2026; 13(35) doi: 10.1002/advs.202516272
|
| 28 |
平 盛. Progress in Surgical Treatment of Colorectal Cancer. Advances in Clinical Medicine 2023; 13(11) doi: 10.12677/ACM.2023.13112510
|
| 29 |
Siyi Qian, Longwu Zeng, Fuxin Chen, Yuxuan Tian, Binjie Zhao, Qiang Liu, Bin Zhang. MCM8 promotes colorectal cancer progression by competitively inhibiting HRD1-mediated CDC42 ubiquitination and degradation. Journal of Translational Medicine 2026; 24(1) doi: 10.1186/s12967-026-07687-0
|
| 30 |
Qing Cao, Ye Tian, Zhiyi Deng, Fangfang Yang, Erfei Chen. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications. International Journal of Molecular Sciences 2024; 25(6) doi: 10.3390/ijms25063358
|
| 31 |
Joanna Słoka, Marcel Madej, Ilona Nowak, Barbara Strzałka-Mrozik. Mesalazine and Lactoferrin as Potential Adjuvant Therapy in Colorectal Cancer: Effects on Cell Viability and Wnt/β-Catenin Pathway. Current Issues in Molecular Biology 2025; 47(5) doi: 10.3390/cimb47050327
|
| 32 |
Mayté Lima-Pérez, Jorge Luis Soriano-García, Vilma Fleites-Calvo, Luis Enrique Alsina-Tul, Dunia Morales-Morgado, Victor Manuel Medina-Pérez, Masiel González-Meisozo, Mircea Betancourt-Cabezas, Carlos Domínguez-Álvarez, Alicia Vargas-Batista, Rolando Uranga-Piña, Ivis Mendoza-Hernández. Nutritional Supplement Ocoxin<sup>®</sup> Combined with Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer. International Journal of Clinical Medicine 2025; 16(09) doi: 10.4236/ijcm.2025.169024
|
| 33 |
Manish Kushwaha, Shubham Chaudhary, Akhilesh Kumar Singh, Govind K. Makharia, Anil Kumar. Bacterial profiling of colorectal cancer biopsies: a culture-based study in Indian patients. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1535477
|
| 34 |
Per Pfeiffer, Chiara Cremolini, Michel Ducreux, Pia Osterlund, Sarah Ronnebaum, Morodoluwa Akin-Fajiye, Victoria Paly, Luis Hernandez, Elena Elez. Survival benefit of oral systemic monotherapy in previously treated metastatic colorectal cancer: a meta-analysis. The Oncologist 2026; 31(7) doi: 10.1093/oncolo/oyag175
|
| 35 |
Gihan Elsisi, Hana Kareem, Abdelaziz Alaseiri, Abdullah Alsharm, Mohamed Al Garni, Hajer Al-Mudaiheem, Fouad Alnagar, Hazem Lotfy, Mohamed Ouda, Ahmed Elshehri. Elsisi G, Abdul Kareem H, Alaseiri A, et al. Costs of Adverse Event Management Associated with First-Line Cetuximab or Panitumumab in Metastatic Colorectal Cancer Patients in Saudi Arabia.. Journal of Health Economics and Outcomes Research 2025; doi: 10.36469/jheor.2025.130878
|
| 36 |
Marco Colella, Andrea Iannucci, Claudia Maresca, Francesco Albano, Carmela Mazzoccoli, Federica Laudisi, Ivan Monteleone, Giovanni Monteleone. SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells. Cancers 2024; 16(13) doi: 10.3390/cancers16132370
|
| 37 |
Daniel M. DePietro, Xin Li, Susan M. Shamimi-Noori. Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?. Seminars in Interventional Radiology 2024; 41(01) doi: 10.1055/s-0043-1777716
|
| 38 |
Umberto Malapelle, Valentina Angerilli, Rossana Intini, Francesca Bergamo, Chiara Cremolini, Federica Grillo, Elena Guerini Rocco, Tiziana Pia Latiano, Erika Martinelli, Nicola Normanno, Fabio Pagni, Paola Parente, Alessandro Pastorino, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Matteo Fassan. Detecting BRAF mutations in colorectal cancer in clinical practice: An Italian experts' position paper. Critical Reviews in Oncology/Hematology 2025; 206 doi: 10.1016/j.critrevonc.2024.104574
|
| 39 |
Yuanfang Cheng. Small protein DDX11-AS1-ORF encoded by lncRNA DDX11-AS1 promotes colorectal cancer progression through VEGFA-activated p38-MAPK pathway. American Journal of Cancer Research 2025; 15(4) doi: 10.62347/VRJE7714
|
| 40 |
Xin Shen, Mengying Xiang, Jiadai Tang, Guangrui Xiong, Ke Zhang, Tingrong Xia, Zhengting Li, Shaoqiong Yang, Xiaoying Chai, Yao Huang, Lin Xie. Evaluation of peripheral blood inflammation indexes as prognostic markers for colorectal cancer metastasis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68150-y
|
| 41 |
Mohammad Arafat, Anthony Wignall, Kyle Brewer, Yunmei Song, Hugo Albrecht, Clive A. Prestidge, Sanjay Garg, Anton Blencowe. Comparison of polymer-coated, drug-eluting self-expandable metal stents for the potential treatment of gastrointestinal cancers. RSC Pharmaceutics 2025; 2(3) doi: 10.1039/D4PM00312H
|
| 42 |
Gui-Lan Xie, Jing Heng, Xiu-Fen Jia, Qian Li, Rui Chang, Nan Zhang, Ling-Ling Xie, Chao Gao. Image and intracavitary electrocardiogram-guided arm port placement in colorectal cancer: A retrospective comparative study. World Journal of Gastrointestinal Surgery 2025; 17(10): 109407 doi: 10.4240/wjgs.v17.i10.109407
|
| 43 |
Djehane Houria Mataam, Assia Galleze, Sarra Benkhelifa, Ryad Trari, Wafa Khelaifia, Said Belhadef, Sabrina Bouhara, Sonia Ait Younes, Anissa Benali, Hassan Mahfouf, Olivier Morales, Houda Belguendouz, Nadira Delhem, Chafia Touil-Boukoffa, Hayet Rafa. NOS2/ARG1 axis and immune cell ratios as promising prognostic and predictive biomarkers for Cetuximab combined with chemotherapy in wt-KRAS human colorectal cancer. Frontiers in Immunology 2026; 16 doi: 10.3389/fimmu.2025.1700487
|
| 44 |
Liuxu Yao, Wen Zhai, Zongming Jiang, Rui He, Weiying Xie, Yuhong Li, Yiyang Hu. The Inhibitory Effects of Propofol on Colorectal Cancer Progression through the
NF-κB/HIF-1α Signaling Pathway. Anti-Cancer Agents in Medicinal Chemistry 2024; 24(11) doi: 10.2174/0118715206283884240326170501
|
| 45 |
Jui-Ning Yeh, Hong-Hwa Chen, Xian-Wu Lan, Chi-Ruei Huang, Yi-Ling Chen, Yi-Ting Wang, Pei-Lin Shao, Sheung-Fat Ko, Jun Guo, Hon-Kan Yip. Alirocumab therapy effectively suppresses colorectal cancer cell growth and invasion in nude mouse liver – PCSK9 is a key driver of PI3K/Akt/p-Bad-mediated cell proliferation and antiapoptotic signaling. International Journal of Surgery 2026; 112(2) doi: 10.1097/JS9.0000000000003728
|
| 46 |
Xinying Zhou, Yu Zhao, Rongchuan Zhao, Shaheryar Shafi, Yue Yang, Guangxing Liu, Song-Bai Liu. Research progress of intestinal microbiota in targeted therapy and immunotherapy of colorectal cancer. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2023.178
|
| 47 |
Qinghui Yang, Hao Zhang, Jing Luo, Hongmei Yu, Xiaodi Yang, Chen Wang. FADS2 inhibits colorectal cancer cell proliferation by regulating ferroptosis through SLC7A11/GPX4. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10395-5
|
| 48 |
Jingjing Zhang, Tiaotiao Chen, Wencheng Wu, Chunhua Hu, Bangting Wang, Xiaofeng Jia, Mujie Ye. Carbonyl reductase 4 suppresses colorectal cancer progression through the DNMT3B/CBR4/FASN/mTOR axis. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03776-0
|
| 49 |
Ho Jin Han, Junyeol Han, Yerim Choi, Gwi-Ja Hwang, Sumin Kim, In-Ja Ryoo, Bo Yeon Kim, Nak-Kyun Soung. A novel tubulin inhibitor, No.07, shows anti-cancer and anti-metastatic effects in colon cancer and tumoroids. Life Sciences 2025; 372 doi: 10.1016/j.lfs.2025.123644
|
| 50 |
Li-Wen Fan, Chao Shang, Qi Lin, Yan-Tao Tian, Dong-Kui Xu. Clinicopathological characteristics and prognostic outcomes of pregnancy-associated colorectal cancer: A 24-year experience. World Journal of Gastroenterology 2025; 31(17): 106508 doi: 10.3748/wjg.v31.i17.106508
|
| 51 |
Tianliang Bai, Ping Li, Yabin Liu, Bindan Cai, Gang Li, Wenbin Wang, Rui Yan, Xiangkui Zheng, Shangkun Du. Knockdown of miR-411-3p induces M2 macrophage polarization and promotes colorectal cancer progression by regulation of MMP7. European Journal of Histochemistry 2025; 69(2) doi: 10.4081/ejh.2025.4178
|
| 52 |
Qi Liu, Yajuan Zhang, Huimin Li, Hong Gao, Yijie Zhou, Dakui Luo, Zezhi Shan, Yufei Yang, Junyong Weng, Qingguo Li, Weiwei Yang, Xinxiang Li. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01649-z
|
| 53 |
Jingjing Zhang, Zhengquan Han, Yajuan Han, Xianfei Xing, Meng Xu. Serum Exosomal Hsa_circ_0005692 as A Novel Biomarker for Colorectal Cancer Metastasis: A Retrospective Observational Study. Applied Biochemistry and Biotechnology 2026; 198(5) doi: 10.1007/s12010-026-05641-w
|
| 54 |
Yung-Fu Chang, Hsing-Hsang Wang, Chih-Wen Shu, Wei-Lun Tsai, Cheng-Hsin Lee, Chun-Lin Chen, Pei-Feng Liu. TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer. Current Issues in Molecular Biology 2023; 45(6) doi: 10.3390/cimb45060287
|
| 55 |
Chen Huang, Lihua Ma, Qiufang Zhao, Yongpeng Mi, Yuanyuan Tian. SEMA6A overexpression inhibited tumor growth and metastasis in colorectal cancer. Brazilian Journal of Medical and Biological Research 2025; 58 doi: 10.1590/1414-431x2025e14896
|
| 56 |
Rohitas Deshmukh. Modulation of Intestinal Flora as an Emerging Therapeutic Approach for the Treatment of Colon Cancer. Current Cancer Therapy Reviews 2025; 21(7) doi: 10.2174/0115733947302126240924050845
|
| 57 |
Gemma Soler, Cristina Grávalos, Fernando Rivera, María José Safont, Anna C. Virgili, Manuel Valladares-Ayerbes, Reyes Ferreiro-Monteagudo, María José Ortiz-Morales, Eduardo Polo-Marques, Irina Kornusova-Bersheva, Elsa Soustre, Weiyu Yao, Elena Élez. Predictive factors of efficacy for FTD/TPI plus bevacizumab in refractory metastatic colorectal cancer patients: a subanalysis of the Spanish cohort from the SUNLIGHT phase III trial. Clinical and Translational Oncology 2025; 27(11) doi: 10.1007/s12094-025-03907-z
|
| 58 |
Hedyieh Karbasforooshan, Hossein Rahimi, Omid Arasteh, Abolghasem Allahyari, Mehdi Varmaghani, Mahdi Jannati, Vahid Ghavami, Mahmoodreza Jaafari, Sepideh Elyasi. Evaluation of Oral Nano-Silymarin Formulation Efficacy in the Prevention of Hand-Foot Syndrome and Neuropathy Induced by XELOX or m-FOLFOX6 Regimens in Metastatic Colorectal Cancer: A Triple-Blinded, Randomized Clinical Trial. Iranian Journal of Pharmaceutical Research 2024; 23(1) doi: 10.5812/ijpr-152364
|
| 59 |
Carmine Pinto, Sara Lonardi, Evaristo Maiello, Erika Martinelli, Michele Prisciandaro, Lisa Salvatore, Andrea Sartore-Bianchi, Mario Scartozzi, Giuseppe Aprile, Chiara Cremolini, Alberto Sobrero. Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion. Frontiers in Oncology 2025; 14 doi: 10.3389/fonc.2024.1502185
|
| 60 |
Lanfang Wu, Jiali Wu, Xinyu Wang, Youfa Xu, Zhizhe Lin, Jianming Chen, Xin Wu. Natural product-based nanotechnological formulations for colorectal cancer treatment. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(10) doi: 10.1007/s00210-025-04175-y
|
| 61 |
HaiLi Li, PeiZhen Gao, QingShui Wang, Chao Xu, FangQin Xue. POU4F1 Drives Colorectal Cancer Progression by Promoting Cell Proliferation, Metastasis, and Chemoresistance. Digestion 2025; 107(2) doi: 10.1159/000548266
|
| 62 |
Qiang Feng, Chen Ni, Fangmin Zhou, Junjia Zhu, Xia Sun, Ya Qin, Nan Xiang, Dan Wu. Clinical relevance of perioperative changes in circulating tumor cells in resectable colorectal cancer. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-15087-8
|
| 63 |
Mengya Sun, Qizhong Shi, Yonghui Mu, Chenglei Li, Wenchao Zhao, Na Han. FXN predicts poor prognosis in colon adenocarcinoma and correlates with immune cell infiltration. Clinical and Translational Oncology 2026; doi: 10.1007/s12094-026-04361-1
|
| 64 |
Matthias P. Fabritius, Jens Ricke. Interventionell-radiologische Therapie von Lebermetastasen kolorektaler Karzinome. Gastroenterologie up2date 2025; 21(01) doi: 10.1055/a-2201-4917
|
| 65 |
Pengcheng Wang, Wenjin Zhong, Qiaozhen Huang, Yuejia Zhu, Liquan Chen, Kai Ye. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer. ACS Biomaterials Science & Engineering 2024; 10(5) doi: 10.1021/acsbiomaterials.3c01531
|
| 66 |
Fei Xing, Ning Liu, Can Wang, Xu-Dong Wang. Caffeic acid phenethyl ester promotes oxaliplatin sensitization in colon cancer by inhibiting autophagy. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-65409-2
|
| 67 |
Kartik Tulsian, Dhinal Thakker, Vivek K. Vyas. Overcoming chimeric antigen receptor-T (CAR-T) resistance with checkpoint inhibitors: Existing methods, challenges, clinical success, and future prospects : A comprehensive review. International Journal of Biological Macromolecules 2025; 306 doi: 10.1016/j.ijbiomac.2025.141364
|
| 68 |
Menghui Wang, Zhanpeng Shi, Yiwen Wang, Jie Lu. Two-stage deep learning framework for laterally spreading tumors detection using self-supervised learning and few-shot classification. DIGITAL HEALTH 2026; 12 doi: 10.1177/20552076261425362
|
| 69 |
Fangyi Li, Linyu Zhou, Biao He, Xiaoli Huang, Chunmei Liu, Qing Li, Qiumei Ma, Tian Xiao, Ruihan Xiao, Ao Tang, Xueqin Qiu, Xiaoju Chen. Trajectories and predictors of benefit finding among patients with colorectal cancer undergoing chemotherapy: A longitudinal observational study. Asia-Pacific Journal of Oncology Nursing 2025; 12 doi: 10.1016/j.apjon.2025.100805
|
| 70 |
Xiaochun Zhang, Xiaorui Ye, Heiying Jin. Oxidized Low-Density Lipoprotein as a Potential Target for Enhancing Immune Checkpoint Inhibitor Therapy in Microsatellite-Stable Colorectal Cancer. Antioxidants 2025; 14(6) doi: 10.3390/antiox14060726
|
| 71 |
Meng-Yue Xiang, Ze-Min Tuo, Xing-Kang Sa, Peng Wang, Ji-Wen Bian, Xin-Ming Zhang. Impact of liver metastasis on the efficacy of immune checkpoint inhibitors for advanced colorectal cancer. World Journal of Gastrointestinal Oncology 2026; 18(2): 115515 doi: 10.4251/wjgo.v18.i2.115515
|
| 72 |
Yuyan Yang, Ping Wang, Yao Yao, Jiaqin Song, Li Wu, Mingyue Xu, Haiyao Liu, Weiwei Zeng, Lei Xia. A Retrospective Cohort Study: Association of Helicobacter Pylori With Radiotherapy Efficacy in Metastatic Colorectal Cancer and Recurrence Risk Following Preoperative Therapy. MedComm – Oncology 2026; 5(2) doi: 10.1002/mog2.70074
|
| 73 |
Xueming Xia, Wei Du, Qiheng Gou. Retrospective stratified analysis of resistance mechanisms to anti-EGFR therapy in mCRC using tumor tissue samples. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-03684-3
|
| 74 |
Mengxi Xiang, Cheng Zhou, Chundong Yao, Jia Liu, Lin Wang, Zheng Wang. A Self-Assembled Irinotecan Nanomedicine Abrogates Steatohepatitis-Induced Liver Metastasis and Potentiates Antitumor Efficacy against Colorectal Cancer. ACS Nano 2026; 20(17) doi: 10.1021/acsnano.6c00855
|
| 75 |
I. Yu. Kokhanovskaia, A. S. Fatyanova, E. A. Tarabrin, I. V. Reshetov. Therapeutic approaches to pulmonary metastases in colorectal cancer. Research and Practical Medicine Journal 2025; 12(3) doi: 10.17709/2410-1893-2025-12-3-6
|
| 76 |
Ghizlane Rais, Farah Boutaagount, Rania Mokfi, Meryem Maskrout, Soundous Bennour, Chaymae Senoussi, Fadoua Rais, Laila Lahlou. The Safety and Effectiveness of Bevacizumab in Metastatic Colorectal Cancer With Unresectable Metastases: A Real-Life Study From the South of Morocco. Cureus 2024; doi: 10.7759/cureus.56733
|
| 77 |
Xiaoxue Pan, Jichang Li, Jing Zhu, Xin Wang, Yucun Liu, Shanwen Chen, Pengyuan Wang. Inhibition of TFF3 improves the infiltration and function of CD8+ T cells by downregulating the expression of PD-L1 in colorectal cancer. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-04964-0
|
| 78 |
Gihan Elsisi, Hana Abdul Kareem, Abdelaziz Alaseiri, Abdullah Alsharm, Mohammed Algarni, Hajer Al-Mudaiheem, Fouad Alnagar, Hazem Lotfy, Mohamed Ouda, Ahmed Elshehri. Costs of Adverse Event Management Associated with First-Line Cetuximab or Panitumumab in Metastatic Colorectal Cancer Patients in Saudi Arabia. Journal of Health Economics and Outcomes Research 2025; 12(1) doi: 10.36469/001c.130878
|
| 79 |
Edward Zheng, Marcin Włodarczyk, Andrzej Węgiel, Aleksandra Osielczak, Maria Możdżan, Laura Biskup, Agata Grochowska, Maria Wołyniak, Dominik Gajewski, Mateusz Porc, Kasper Maryńczak, Łukasz Dziki. Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1398289
|
| 80 |
Hsin-Chih Chen, Ching-Ying Chen, Pao-Yuan Wang, Pin-Yu Su, Shu-Ping Tsai, Chi-Pei Hsu, Hsiao-Sheng Liu, Chi-Ying F. Huang, Wen-Hsing Cheng, Ming-Fen Lee, Chun-Li Su. Using Integrated Bioinformatics Analysis to Identify Saponin Formosanin C as a Ferroptosis Inducer in Colorectal Cancer with p53 and Oncogenic KRAS. Antioxidants 2025; 14(8) doi: 10.3390/antiox14081027
|
| 81 |
Qican Deng, Yajun Chen, Zhenzhou Chen, Zhongxue Fu. SPIB suppresses protective autophagy via the IFIT2/PINK1/Parkin axis to promote anoikis in colorectal cancer. Cancer Cell International 2026; 26(1) doi: 10.1186/s12935-026-04185-7
|
| 82 |
Jie Ni, Chu-Gen Wan, Zi-Qi Sui. Efficacy and safety of radiotherapy in patients with microsatellite stable or proficient mismatch repair colorectal cancer liver metastasis. World Journal of Gastrointestinal Oncology 2025; 17(3): 102873 doi: 10.4251/wjgo.v17.i3.102873
|
| 83 |
Jinyi Xu, Xiaoqiang Niu. Assessing the Therapeutic Value of Primary Tumor Resection in Colorectal Cancer Lung Metastases: A Dynamic Visualization Clinical Tool Constructed Based on the SEER Database. Journal of Gastroenterology and Hepatology 2025; 40(5) doi: 10.1111/jgh.16911
|
| 84 |
Mohammad Javad Bazyari, Ali Ahmadizad Firouzjaei, Seyed Mahdi Ahmadi, Mohsen Khorashadizadeh, Seyed Hamid Aghaee-Bakhtiari. Exploiting network-based drug repositioning to target metastasis in colorectal cancer: In-Silico prediction and in-vitro evidence. Molecular and Cellular Probes 2025; 84 doi: 10.1016/j.mcp.2025.102053
|
| 85 |
Kuen-Tze Lin, Yu-Chieh Hsieh, Pi-Kai Chang, Chih-Wei Lai, Shih-Yu Lee, I-Chuan Yen. 4‑Acetylantrocamol LT3 suppresses colorectal cancer growth and metastasis via PI3K/AKT and MAPK pathway modulation. International Journal of Molecular Medicine 2026; 57(5) doi: 10.3892/ijmm.2026.5797
|
| 86 |
Kamran Ali, Yang Li, Qiuchen Bi, Xiaolin Zhu, Xiaoli Sun, Heping Zhu, Huamiao Zhang, Leyi Huang, Honghua Hu, Xiaohui Yang, Longguang Tang, Jianwei Wang. Nanocarriers engineering for efficient NSUN2 silencing and immune responsive therapy in metastatic colorectal cancer. Materials Today Bio 2026; 38 doi: 10.1016/j.mtbio.2026.103116
|
| 87 |
Jie Zhang, Weijuan Jiang. Survival benefits of immunotherapy combined with chemoradiotherapy in metastatic colorectal cancer: an analysis based on data from the SEER database. Open Medicine 2026; 21(1) doi: 10.1515/med-2026-1416
|
| 88 |
Devanshi D. Patel, Paxton V. Dickson. Invited Editorial About: “Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer,” by C. Komine et al.. Annals of Surgical Oncology 2025; 32(3) doi: 10.1245/s10434-024-16609-7
|
| 89 |
Guillermo Valenzuela, Héctor R. Contreras, Katherine Marcelain, Mauricio Burotto, Jaime González-Montero. Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment. International Journal of Molecular Sciences 2025; 26(3) doi: 10.3390/ijms26031168
|
| 90 |
Daniel Tobón-Vélez, Mallorie Tourbin, Ana María Sepúlveda, Ana María Castañeda-Cifuentes, Christine Frances, Johanna Pedroza-Díaz. Biological effects of chlorogenic acid nanoformulations on colorectal cancer cells. Journal of Drug Delivery Science and Technology 2026; 115 doi: 10.1016/j.jddst.2025.107744
|
| 91 |
Run-Zhi Deng, Xin Zheng, Zhong-Lei Lu, Ming Yuan, Qi-Chang Meng, Tao Wu, Yu Tian. Effect of colorectal cancer stem cells on the development and metastasis of colorectal cancer. World Journal of Gastrointestinal Oncology 2024; 16(11): 4354-4368 doi: 10.4251/wjgo.v16.i11.4354
|